The involvement of IL-1 in regulation of insulin sensitivity is highlighted by a recent observation that the IL-1 blocking agent improved IR in rheumatoid arthritis patients with comorbid type 2 diabetes (T2D) [55]. Here, IL1A is linked to type 2 diabetes mellitus.